Tattoos that change lives
UC Cancer Institute physicians bring 3D tattooist to campus to teach practitioners how to perform 3D areola tattoos on local patients
On Oct. 14-15, Beth Fairchild, a medical tattooist from North Carolina, visited the University of Cincinnati medical campus and taught UC Health practitioners how to perform 3D areola tattoos on patients who undergo mastectomy, reconstruction or other surgeries that leave them without natural nipples or areolae.
Elizabeth Burton was one of the patients who volunteered to be tattooed during the training, and now, she feels like her journey is complete.
Find out more about the reconstrutive team.
The UC Cancer Institute’s Breast Cancer Center will also discuss options like this and other innovations in the field at the annual educational symposium, titled “Breast Cancer Prevention, Detection and Treatment: Innovations Around Every Corner,” Saturday, Nov. 2. Learn more and register.
Related Stories
Chris Higgins named UC Foundation Vice President for Development, Academic Health Enterprise
January 6, 2026
The University of Cincinnati Foundation is pleased to welcome Chris Higgins as the new Vice President for Development, Academic Health Enterprise.
What's behind the mysterious rise of migraines?
January 5, 2026
Weather patterns such as extreme heat and storm conditions have been linked to migraine attacks, and research shows those environmental conditions are becoming more common. As National Geographic recently reported, one of the leading theories behind this mysterious rise is that climate change may be playing a role.
Top six 2025 nephrology drug approvals
January 5, 2026
“2025 has been a landmark year for kidney disease therapeutics, marked by a comprehensive slate of FDA approvals covering endothelin-receptor blockade, complement inhibition, GLP-1-based metabolic protection, and B-cell-directed therapy,” Prakash Gudsoorkar, MD, associate professor of clinical medicine at the University of Cincinnati College of Medicine and staff nephrologist at UC Health, recently told MedCentral.